KNWN - Know Labs, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.9100
-0.0900 (-4.50%)
At close: 3:07PM EST
Stock chart is not supported by your current browser
Previous Close2.0000
Open1.9950
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.8500 - 1.9950
52 Week Range0.9000 - 2.9700
Volume11,732
Avg. Volume22,490
Market Cap35.219M
Beta (5Y Monthly)2.97
PE Ratio (TTM)N/A
EPS (TTM)-0.4220
Earnings DateFeb 09, 2020 - Feb 13, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Know Labs Discusses Intellectual Property Strategy

    Know Labs, Inc. (OTCQB: KNWN) today reviewed its intellectual property strategy for investors as it moves into the 2020 calendar year. As discussed in its recent annual 10-K filing, the Company has pursued for several years an ambitious intellectual property strategy focused on patent filings, trademarks, copyrights and trade secrets.

  • Know Labs Unveils New UBAND Design and Smartphone App
    Business Wire

    Know Labs Unveils New UBAND Design and Smartphone App

    Know Labs, Inc. (KNWN) unveiled today a first look at its wearable UBAND™ Continuous Glucose Monitor (CGM) along with its companion iPhone App. Bosua revealed the new UBAND design and iPhone App in this short 1 minute video. UBAND will provide people with an easy, pain-free way to monitor their blood glucose levels.

  • Business Wire

    Know Labs Expands Advisory Board

    Know Labs, Inc. (KNWN) – a creator and provider of diagnostic solutions, announced today that Larry K. Ellingson has joined its Medical, Scientific and Regulatory Advisory Board. The Advisory Board was formed to provide counsel and guidance to the Company and its senior management as they work toward FDA approval of their non-invasive UBAND Continuous Glucose Monitor. The Advisory Board is chaired by Know Labs Chief Medical Officer, James (Andy) Anderson, M.D.

  • Business Wire

    Know Labs Announces Racer Technology as Manufacturing Partner

    Know Labs, Inc. (KNWN) a provider of diagnostic solutions, today announced Racer Technology Pte. Ltd. will manufacture its wearable UBAND Calorie Counter and later its wearable UBAND Continuous Glucose Monitor (CGM). Racer Technology, a medical device and wearables manufacturer, is headquartered in Singapore with factories across Asia. Racer Technology, led by CEO, Willy Koh, has state of the art manufacturing processes and a workforce trained in the latest manufacturing techniques.

  • Know Labs Announces Formation of Advisory Board
    Business Wire

    Know Labs Announces Formation of Advisory Board

    Know Labs, Inc. (KNWN) – a creator and provider of diagnostic solutions, announced today the formation of its Medical, Scientific and Regulatory Advisory Board, the initial members of the Advisory Board and its first meeting. The Advisory Board was formed to provide counsel and guidance to the Company and its senior management, CEO Phil Bosua and Chairman and Founder, Ron Erickson. The Advisory Board is chaired by Know Labs Chief Medical Officer, James (Andy) Anderson, M.D.

  • Mark Tapsak, Ph.D., Joins Know Labs as Vice President
    Business Wire

    Mark Tapsak, Ph.D., Joins Know Labs as Vice President

    Know Labs, Inc. (KNWN) a provider of diagnostic solutions, announced today that Mark Tapsak, Ph.D. has joined the Company as Vice President, Intellectual Property. In addition to Dr. Tapsak’s focus on intellectual property at Know Labs he will work to support the product development, manufacturing and launch of the Company’s UBAND Calorie Counter wearable and help drive toward FDA approval of the Company’s non-invasive UBAND Continuous Glucose Monitor. At Dexcom, a multi-billion dollar provider of continuous glucose monitoring (CGM) systems, Dr. Tapsak was the 12th employee.

  • Business Wire

    Know Labs Bio-RFID™ Platform Technology Identifies Blood Alcohol Levels

    Know Labs, Inc. (KNWN) – a provider of diagnostic solutions, released today a video presentation of its Bio-RFID™ platform technology’s successful identification of blood alcohol levels. In the video presentation, CEO Phil Bosua not only discusses the Company’s use of Bio-RFID to detect blood alcohol levels, but the broad implications for its technology platform. “Over the last month we’ve been powering through a ton of experiments and innovations and are really happy to report we’ve now got an AI based algorithm that allows our technology to detect blood alcohol levels non-invasively.